Literature DB >> 9620206

Expression of recombinant hepatitis C virus non-structural protein 5B in Escherichia coli.

R H Al1, Y Xie, Y Wang, C H Hagedorn.   

Abstract

The hepatitis C virus (HCV) represents a major public health problem that can produce liver failure and hepatocellular carcinoma in chronically infected patients. Our goal was to express the HCV non-structural protein 5B (NS5B) protein of HCV genotype 1a in Escherichia coli and initiate studies of its role in HCV genomic replication. In this report we demonstrate that a recombinant NS5B protein with an amino terminal sequence of ASMSYSWTG has RNA-dependent RNA polymerase (RDRP) activity. This recombinant enzyme was active in poly(U) polymerase assays and produced template-sized RNA products when globin mRNA was used as a template. The polymerase activity of recombinant NS5B was primer-dependent and was active for at least 60 min of incubation at 30 degrees C. Deletion of the carboxyl terminal region of HCV NS5B resulted in a loss of RDRP activity indicating that the enzymatic activity observed was due to the full-length recombinant enzyme. Recombinant NS5B (RDRP) should assist in understanding the mechanism of HCV replication and the identification of specific enzyme inhibitors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620206     DOI: 10.1016/s0168-1702(97)00147-0

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  13 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Specific interaction between the hepatitis C virus NS5B RNA polymerase and the 3' end of the viral RNA.

Authors:  J C Cheng; M F Chang; S C Chang
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependent RNA polymerases: implication for viral RNA synthesis.

Authors:  C T Ranjith-Kumar; J Gajewski; L Gutshall; D Maley; R T Sarisky; C C Kao
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase.

Authors:  W Zhong; A S Uss; E Ferrari; J Y Lau; Z Hong
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Antiviral drugs against hepatitis C virus.

Authors:  Sidra Rehman; Usman A Ashfaq; Tariq Javed
Journal:  Genet Vaccines Ther       Date:  2011-06-23

6.  Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.

Authors:  Ginette McKercher; Pierre L Beaulieu; Daniel Lamarre; Steven LaPlante; Sylvain Lefebvre; Charles Pellerin; Louise Thauvette; George Kukolj
Journal:  Nucleic Acids Res       Date:  2004-01-22       Impact factor: 16.971

7.  Identification of a C-terminal regulatory motif in hepatitis C virus RNA-dependent RNA polymerase: structural and biochemical analysis.

Authors:  Vincent J-P Lévêque; Robert B Johnson; Stephen Parsons; Jianxin Ren; Congping Xie; Faming Zhang; Q May Wang
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli.

Authors:  E Ferrari; J Wright-Minogue; J W Fang; B M Baroudy; J Y Lau; Z Hong
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Reconstitution and Functional Analysis of a Full-Length Hepatitis C Virus NS5B Polymerase on a Supported Lipid Bilayer.

Authors:  Nam-Joon Cho; Edward A Pham; Rachel J Hagey; Vincent J Lévêque; Han Ma; Klaus Klumpp; Jeffrey S Glenn
Journal:  ACS Cent Sci       Date:  2016-06-13       Impact factor: 14.553

10.  Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Licia Tomei; Sergio Altamura; Linda Bartholomew; Antonino Biroccio; Alessandra Ceccacci; Laura Pacini; Frank Narjes; Nadia Gennari; Monica Bisbocci; Ilario Incitti; Laura Orsatti; Steven Harper; Ian Stansfield; Michael Rowley; Raffaele De Francesco; Giovanni Migliaccio
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.